Essilorluxottica (EL)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA and an Investment Account
Sell

€247.70

Buy

€250.70

arrow-up€6.80 (+2.81%)

Prices updated at 12 May 2025, 16:35 CEST
| Prices minimum 15 mins delay
|
Prices in EUR

Essilor International SA designs, manufactures, purchases, sells and trades all eyewear and optical products. It also manufactures purchases and sales frames, sunglasses and other protective equipment, lenses and contact lenses.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Chairman
Mr. Francesco Milleri
CEO
Mr. Francesco Milleri
Most recent earnings
31 Dec 2024
Fiscal year end
31 Dec 2024
Employees
200,000
Head office
147, Rue de Paris
Paris
France
94220
mobile
+33 149774224
letter
IR@essilor-luxottica.com

Key personnel

Salary
Mr. Paul du Saillant
Deputy Chief Executive Officer and Director
-
Ms. Marie-Christine Coisne-Roquette
Independent Director
-
Dr. Swati A. Piramal
Independent Director
-
Mr. Mario Notari
Director
-
Mr. Francesco Milleri
Chief Executive Officer and Chairman of the Board
-
Ms. Cristina Scocchia
Independent Director
-
Mr. Andrea Zappia
Independent Director
-
Mr. Romolo Bardin
Director
-
Mr. Jean-Luc Biamonti
Independent Director
-
Dr. Nathalie von Siemens
Independent Director
-
Ms. Virginie Mercier Pitre
Director
-
Ms. Margot Bard
Director
-
Mr. Sebastien Brown
Director
-
Mr. Jose Gonzalo
Independent Director
-

Top 5 shareholders

No. of shares
Capital Research and Management Company20,252,458
Capital Group18,783,258
Vanguard Group Inc8,884,847
American Funds New Perspective Fund7,446,311
Capital Group New Perspective Comp7,446,311

Director dealings

Action
No data
Please note that past performance is not a reliable indicator of future returns.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.